Last reviewed · How we verify
Vitamin B12-ratiopharm N, injection solution — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Vitamin B12-ratiopharm N, injection solution (Vitamin B12-ratiopharm N, injection solution) — Swedish Orphan Biovitrum. Vitamin B12-ratiopharm N facilitates the metabolism of homocysteine and methylmalonyl-CoA by acting as a cofactor for methionine synthase and methylmalonyl-CoA mutase.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vitamin B12-ratiopharm N, injection solution TARGET | Vitamin B12-ratiopharm N, injection solution | Swedish Orphan Biovitrum | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vitamin B12-ratiopharm N, injection solution CI watch — RSS
- Vitamin B12-ratiopharm N, injection solution CI watch — Atom
- Vitamin B12-ratiopharm N, injection solution CI watch — JSON
- Vitamin B12-ratiopharm N, injection solution alone — RSS
Cite this brief
Drug Landscape (2026). Vitamin B12-ratiopharm N, injection solution — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-b12-ratiopharm-n-injection-solution. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab